Featured Article

Having a rounder heart may indicate increased risk for atrial fibrillation and cardiomyopathy, suggest study findings.

Precision Oncology Today


Broadening the Scope of Clinical Trials: The Changing Role of Real-World Evidence

For many years, drug developers and regulators have collected real-world data (RWD) on adverse events linked to newly approved medicines. However, this data has not played a significant role in developing or executing pre-approval clinical trials. The situation is now changing.
man and woman in lab coat

An Epigenetic Exploration of Cancer

Looking beyond genes alone as the drivers of this collection of diseases promises to improve treatment and might one day lead to prevention.

How Artificial Intelligence Is Driving Changes in Radiology

The umbrella term artificial intelligence (AI) encompasses the subfields of machine learning. With the advent of AI came the emergence of radiomics, where digital images that are normally interpreted by radiologists in a qualitative way are transformed into quantitative data.

Trending on Inside Precision Medicine

Doctor with cancer patient

New Draft Guidance from FDA Looks to Refine Accelerated Approval of Oncology Drugs

The FDA published draft guidance regarding the design of clinical trials that the agency hopes can support the accelerated approval (AA) applications for drugs entering oncology clinical trials.
Lung cancer, artwork

Lung Cancer Growth Suppressed by Anticancer and Antifibrotic Drug Combo

Researchers at Academia Sinica, National Yang Ming Chiao Tung University, National Taiwan University Hospital, and National Taiwan University, have shown how blocking the activity of fibroblasts can help to treat lung cancer.
T-Cells Attacking Cancer Cell

Time of Day May Be Important for Cancer Diagnosis and Treatment

Key biologic features of tumor progression are influenced by the circadian rhythm, which could be used to optimize timing of drug delivery and maximize safety and efficacy.

Daily News


Inside Precision Medicine